by Nicole Kuchinsky | Dec 5, 2017
One of my personal highlights from this year’s Till and McCulloch Meetings was attending the “Science for Citizens” panel (reported on in a previous post). Experts including Timothy Caulfield, patient advocate William Brock, and National Post writer Tom...
by Hamideh Emrani | Nov 16, 2017
This year, Dr. Harold Atkins was honored with the Till & McCulloch Award. He and Dr. Mark Freedman led a clinical trial that used stem cells to reset the immune system as a treatment strategy for Multiple Sclerosis (MS) and a few other neurodegenerative...
by Hamideh Emrani | Nov 9, 2017
Another interesting talk, on the first morning of the Canadian Till & McCulloch Meetings, was from Dr. Bruce Verchere who spoke about possible routes to prevent graft rejection in the case of human β-cell and islet cell transplants for diabetes through...
by Hamideh Emrani | Nov 8, 2017
This year’s Till & McCulloch Meetings began with a rainy day on the beautiful mountainside in Mont-Tremblant, Quebec. The morning talks started off with Dr. Matthias Lütolf. His lab at the École Polytechnique Fédérale de Lausanne, (EPFL) works on strategies to...
by Samantha Payne | Oct 3, 2017
The brain is one of the most complex and delicate organs of the body, with very little capacity to regenerate itself. As such, any disease or injury it sustains is a challenge for regenerative medicine researchers to design effective strategies. Therapeutics need to...
Comments